Francavilla Fontana, Italy

Giampiero Ventimiglia

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **The Innovations of Giampiero Ventimiglia**

Introduction

Giampiero Ventimiglia, an accomplished inventor hailing from Francavilla Fontana, Italy, has made significant contributions to the field of pharmaceuticals. With a keen focus on the crystalline forms of Eluxadoline, he has pioneered methods that enhance the compound's functionality and application in medicine. His innovative work exemplifies the spirit of modern inventorship.

Latest Patents

Ventimiglia is the holder of one patent, which centers on "Eluxadoline crystalline forms and processes for their preparation." This patent describes novel crystalline forms of Eluxadoline, characterized by their specific formula, alongside innovative processes for their synthesis. This advancement stands to benefit pharmaceutical preparations and applications significantly.

Career Highlights

Ventimiglia is associated with Quimica Sintetica S.A., a company recognized for its dedication to chemical synthesis and pharmaceutical research. In his role, he has contributed to the development of new chemical processes that push the boundaries of current pharmaceutical capabilities.

Collaborations

Throughout his career, Ventimiglia has collaborated with notable colleagues, including Giuseppe Barreca and Norberto Masciocchi. These partnerships have fostered a creative and productive environment, enabling groundbreaking discoveries in their shared field of expertise.

Conclusion

Giampiero Ventimiglia's innovative approach and dedication to his work underscore the vital role of inventors in advancing modern science. With his contributions to the field of pharmaceuticals, he not only enhances the understanding of Eluxadoline but also paves the way for future innovations that may improve patient outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…